Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
Schmid P, Untch M, Kossé V, Bondar G, Vassiljev L, Tarutinov V, Lehmann U, Maubach L, Meurer J, Wallwiener D, Possinger K. Schmid P, et al. Among authors: possinger k. J Clin Oncol. 2007 Jun 20;25(18):2509-15. doi: 10.1200/JCO.2006.08.8534. J Clin Oncol. 2007. PMID: 17577027 Clinical Trial.
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study.
Schmid P, Krocker J, Morack G, Heilmann V, Blohmer JU, Michniewicz K, Köhler G, Schaller-Kranz T, Possinger K, Elling D. Schmid P, et al. Among authors: possinger k. J Cancer Res Clin Oncol. 2004 Nov;130(11):657-63. doi: 10.1007/s00432-004-0599-y. Epub 2004 Aug 20. J Cancer Res Clin Oncol. 2004. PMID: 15322862 Clinical Trial.
Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P, Untch M, Wallwiener D, Kossé V, Bondar G, Vassiljev L, Tarutinov V, Kienle E, Lüftner D, Possinger K; TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate). Schmid P, et al. Among authors: possinger k. Anticancer Res. 2002 Jul-Aug;22(4):2325-32. Anticancer Res. 2002. PMID: 12174922 Clinical Trial.
Advanced breast cancer: a phase II trial with gemcitabine.
Carmichael J, Possinger K, Phillip P, Beykirch M, Kerr H, Walling J, Harris AL. Carmichael J, et al. Among authors: possinger k. J Clin Oncol. 1995 Nov;13(11):2731-6. doi: 10.1200/JCO.1995.13.11.2731. J Clin Oncol. 1995. PMID: 7595731 Clinical Trial.
Gemcitabine for palliative treatment in metastatic breast cancer.
Lüftner D, Flath B, Akrivakis C, Grunewald R, Mergenthaler HG, Possinger K. Lüftner D, et al. Among authors: possinger k. J Cancer Res Clin Oncol. 1998;124(10):527-31. doi: 10.1007/s004320050210. J Cancer Res Clin Oncol. 1998. PMID: 9829855 Review.
253 results